BRAF, PIK3CA, and PTEN status and benefit from cetuximab (CET) in the treatment of advanced colorectal cancer (CRC): Results from NCIC CTG/AGITG CO.17
Jonker, Derek J., Karapetis, Christos Stelios, O'Callaghan, Christopher J., Marginean, Celia, Zalcberg, John Raymond, Simes, John, Moore, Malcolm J., Tebbutt, Niall Christopher, Price, Timothy Jay, Daneshmand, Manijeh, Hanson, Jennifer, Shapiro, Jeremy David, Pavlakis, Nick, Gibbs, Peter, Van Hazel, Guy A., Yu Min Lee, Ursula Joan, Haq, Rashida, Virk, Shakeel, Tu, Dongsheng, Lorimer, Ian
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article